CELG News 158.82 06/05/2014 04:33:56 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 158.82 $CELG

Final Glance: Biotechnology companies
AP - Wed Jun 04, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:

After Yesterday's Rally of 2.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 04, 3:45PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $154.22 to a high of $159.23. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $155.71 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Celgene to Potentially Pullback after Yesterday's 2.13% Rise
Comtex SmarTrend(R) - Wed Jun 04, 3:44PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $154.22 to a high of $159.23. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $155.71 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Midday Glance: Biotechnology companies
AP - Wed Jun 04, 12:21PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Early Glance: Biotechnology companies
AP - Wed Jun 04, 9:50AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:

Bargains in Biotech? Yes, They Exist
Cheryl Swanson, The Motley Fool - Motley Fool - Tue Jun 03, 5:00PM CDT
Bargains in biotech? Isn't that an awfully good example of an oxymoron? Not according to a new study conducted by Richard Evans, a longtime Wall Street analyst. The study focuses on something that is inherently difficult: valuing a company's...

3 Reasons Celgene Is a Buy
Cory Renauer, The Motley Fool - Motley Fool - Mon Jun 02, 5:30PM CDT
Celgene was the subject of a recent downgrade from "overweight" to "neutral" by JPMorgan. Analysts didn't cite new concerns, but that won't stop media from speculating. In the face of uncertainty now is a great time to revisit the bull argument for...

Stock Market News for June 02, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 9:06AM CDT
Benchmarks ended Friday’s trading session little changed following mixed economic reports

Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014
Business Wire - Sun Jun 01, 8:00AM CDT
Celgene Corporation (NASDAQ: CELG) today announced updated Overall Survival (OS) results from a post-hoc analysis of its phase III MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study of ABRAXANE(R) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine in treatment-naive patients with metastatic pancreatic cancer. A poster discussion of the analysis is scheduled for Sunday, June 1st at 11:30 am CT at the 50th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Ill.

Biogen Idec
at Investor's Business Daily - Thu May 29, 5:48PM CDT
Biogen Idec (BIIB) rose 4% after JPMorgan upgraded its stock to overweight from neutral, citing positive opinions on oral multiple-sclerosis drug Tecfidera, and hiked its price target to 375 from 300. JPMorgan cut Celgene (CELG) to neutral from...

Scorned Pfizer Should Forget AstraZeneca and Buy Celgene Instead
Todd Campbell, The Motley Fool - Motley Fool - Thu May 29, 5:30PM CDT
AstraZeneca played hard to get and won, at least for now. The British pharmaceutical major this month rejected two nine-figure buyout offers from   Pfizer , which now must wait at least three months before making  any additional offers. ...

Array BioPharma Collaborates with Biogen - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 29, 4:10PM CDT
Array BioPharma (ARRY) announced that it has entered into a drug discovery collaboration agreement with Biogen Idec (BIIB).

Biogen Upgraded, Celgene Downgraded On Pipelines
at Investor's Business Daily - Thu May 29, 2:18PM CDT
Big-cap biotechs Biogen Idec (BIIB) and Celgene (CELG) were headed in opposite directions on the stock market today after JPMorgan upgraded one and downgraded the other. JPMorgan analyst Geoff Meacham lifted his rating on Biogen to overweight from...

Stocks Slightly Higher Amid Mixed Data; S&P 500 Logs New High
at Investor's Business Daily - Thu May 29, 9:32AM CDT
Stocks opened modestly higher Thursday despite mixed economic data. The Nasdaq climbed 0.4% to its best levels since early April. The S&P 500 rose 0.2% to a record high. Meanwhile, the Dow Jones industrial average ticked up 0.1%. Volume was tracking...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LAZ Parking and indiGOtech's Bold EV Charging Move

Updated Category News Views 9

EV Chargers: The Future Parked Closer? I've been around the block more times than a cabbie in Manhattan rush hour, and let me tell you, when it comes to EVs, folks are still playing catch-up. But here's a kicker—LAZ Parking and indiGOtech have decided they're not gonna wait around. This joint venture of theirs aims to sock some sense into the old condo complex parking...

Continue Reading
Knexus Teams with Google Cloud to Boost Public Sector AI

Updated Category News Views 5

Kicking Off a New Era for AI in Government There's a fresh wind blowing in how government agencies approach artificial intelligence, and it’s got Knexus and Google Cloud’s Gemini initiative written all over it. Set in Vienna, Virginia, the announcement rolls out a heavy-hitting collaboration that might just rewire how public sectors handle data. October 20, 2026,...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 9

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Millrose Investors Face Unveiling of Financial Missteps

Updated Category News Views 8

A Cold Shower for Millrose Properties' Investors Investing in Millrose Properties, Inc. (NYSE: MRP) didn't quite pan out as some folks hoped. On the heels of Hunterbrook's report about dubious deals, the Company's stock tumbled 8.53%, smacking investors with a not-so-gentle reminder of market realities. Sure, stocks can dip and dive like a rollercoaster, but when it...

Continue Reading
DARPA Pumps $10.7M into RxMP's Hemorrhage Control Drug

Updated Category News Views 5

RxMP Therapeutics Lands a DARPA Deal Would you look at that—RxMP Therapeutics just got handed a load of cash thanks to some good old government backing. Up to $10.7 million from DARPA is no chump change. It's like finding a lifeboat right when you're treading water out there in the big bad sea. This award under the RAPIID program is set to move the needle for RxMP’s...

Continue Reading
Software Tax Hits Enterprises: Costly Control Concerns

Updated Category News Views 11

Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...

Continue Reading
PG&E Delivers $26M Climate Credit to Small Biz

Updated Category News Views 9

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Continue Reading
Top Gun F/A-18 Super Hornet Lands at Palm Springs

Updated Category News Views 3

Aviation Marvel Now Anchored at Palm Springs There's something electric about standing next to a piece of history, especially when it involves the thunderous scream of an F/A-18 Super Hornet. The Palm Springs Air Museum is pulling back the curtains on an experience that's got aviation buffs and Top Gun fans buzzing like bees. On November 7, 2026, this central hub of...

Continue Reading
DICK'S Sporting Goods Faces Legal Challenges in Securities Suit

Updated Category News Views 0

Trouble Brewing at DICK'S Sporting Goods Wall Street's not only about the wins. There are moments when the market throws a curveball, and right now, DICK'S Sporting Goods is facing a fast one. DJS Law Group just laid out a class action lawsuit accusing them of bending the securities law rules. It ain't pretty when a company gets tangled up in legal battles, but it's...

Continue Reading
BRAC Bank Taps Finastra for Trade Finance Transformation

Updated Category News Views 4

Bangladesh's BRAC Bank Embarks on Tech Transformation If ever there was a time for a bank to shake things up, BRAC Bank in Bangladesh decided it's now. Partnering up with Finastra, they're on a mission to modernize their trade finance operations, and they're banking on these changes to keep them relevant and competitive in a shaky global economy. Streamlining Trade...

Continue Reading

Top 5 Most Recently Viewed Articles

UPL Ltd Reports Impressive FY25 Results with Record Growth

Updated Category News Views 566

Exceptional Financial Performance by UPL Ltd UPL Ltd has reported impressive financial results for the fiscal year ending March 31, 2025. With a remarkable growth trajectory, the company has achieved an 8% increase in revenue, significantly bolstered by a robust performance in volume sales and operational improvements. Key Financial Highlights for FY25 In the fourth...

Continue Reading
Energy Transfer: A High-Yield Investment Opportunity

Updated Category News Views 164

Overview of Energy Transfer Energy Transfer (NYSE: ET) stands out as a leading provider of midstream energy services in the United States. This vast operation generates a significant amount of cash flow, with approximately half of it returned to investors. With a yield surpassing 8%, Energy Transfer is particularly appealing for those seeking income from their...

Continue Reading
Ithaca Energy Executives Enhance Stake Through Incentives

Updated Category News Views 105

Ithaca Energy's Executives Active in Share Incentive Plan Ithaca Energy plc has announced recent activities under its Share Incentive Plan (SIP) showing the proactive involvement of its senior management. This initiative facilitates executives to buy additional shares through the reinvestment of cash dividends. Details of Recent Share Purchases In a move reflecting...

Continue Reading
Inhibrx Biosciences Reveals Promising Phase 1 Trial Insights

Updated Category News Views 162

Inhibrx Biosciences Shares Exciting Trial Results for Ozekibart Inhibrx Biosciences, Inc. (Nasdaq: INBX), a biopharmaceutical company dedicated to innovative cancer treatments, recently shared promising preliminary data from the Phase 1 trial of ozekibart (INBRX-109). This groundbreaking treatment is being investigated in combination with FOLFIRI for patients battling...

Continue Reading
Norwegian Shares Slip as Market Sees Mixed Sector Performance

Updated Category News Views 238

Norwegian Stock Market Overview On a recent trading day, Norwegian stocks faced a downturn with notable declines across key sectors including media, transportation, and diversified financials. This trend in the stock market has sparked discussions about the underlying factors influencing these fluctuations. Oslo OBX Index Performance The Oslo OBX index, which serves as a...

Continue Reading